POOR ADHERENCE
Decreased Drug Efficacy
The patient loses as poor adherence limits effective management and control of chronic illnesses.
Poor Outcome
The doctor loses credibility with the patient as his health deteriorates
Increased Care Costs
Medical Aid & Payer loses at the patient does not recover
Lost Sales
Pharmaceutical Industry loses because of lost sales due to early dropout
+ PHARMACALL =



ROBUST ADHERENCE
Increased Drug Efficacy
The patient wins as robust adherence effectively manages and controls chronic illnesses.
Improved Outcome
The Doctor gains credibility as the patients health improves
Decreased Care Costs
Medical Aid & Payer wins as the patient recovers and expenses drop
Retained Sales
Pharmaceutical Industry wins as sales are retained due to late or no dropout
By bridging the gap “beyond the prescription” we are able to ensure that all role players benefit, from the Patient to the Doctor to Funder and Manufacturer
EXPERIENCE, KNOWLEDGE and TECHNOLOGY
SUCCESS BEYOND the PRESCRIPTION